{"transactions":[{"id":2164,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-03T20:14:24.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":7405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of September 1, 2026."}],"balance_after":7405,"derivative":{"exercise_price":0,"expiration_date":"2029-09-01","underlying":"Common Stock","underlying_shares":7405},"source":{"system":"sec-edgar","filing":"0000875045-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661567/000087504526000082/form4.xml","form_type":"4"}},{"id":379383,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-26T21:18:21.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":354,"price":216.26,"value":76556.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $216.26 (range $215.79 to $216.76)."}],"balance_after":30837,"source":{"system":"sec-edgar","filing":"0001209191-21-014736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014736/doc4.xml","form_type":"4"}},{"id":379382,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-26T21:18:21.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":680,"price":214.28,"value":145710.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $214.28 (range $213.90 to $214.69)."}],"balance_after":31191,"source":{"system":"sec-edgar","filing":"0001209191-21-014736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014736/doc4.xml","form_type":"4"}},{"id":379381,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-26T21:18:21.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":1348,"price":213.04,"value":287177.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $213.04 (range $212.76 to $213.68)."}],"balance_after":31871,"source":{"system":"sec-edgar","filing":"0001209191-21-014736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014736/doc4.xml","form_type":"4"}},{"id":379380,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-26T21:18:21.000Z","date":"2021-02-25","kind":"sale","acquired":false,"shares":646,"price":211.58,"value":136680.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $211.58 (range $211.34 to $211.91)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":33219,"source":{"system":"sec-edgar","filing":"0001209191-21-014736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014736/doc4.xml","form_type":"4"}},{"id":379379,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-26T21:18:21.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":2416,"price":217.57,"value":525649.12,"ownership":{"direct":true},"balance_after":33865,"source":{"system":"sec-edgar","filing":"0001209191-21-014736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014736/doc4.xml","form_type":"4"}},{"id":379877,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-19T21:18:18.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":200,"price":213.45,"value":42690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $213.45 (range $213.30 to $213.68)."}],"balance_after":36281,"source":{"system":"sec-edgar","filing":"0001209191-21-012347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012347/doc4.xml","form_type":"4"}},{"id":379876,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-19T21:18:18.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1952,"price":212.56,"value":414917.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $212.56 (range $212.25 to $212.95)."}],"balance_after":36481,"source":{"system":"sec-edgar","filing":"0001209191-21-012347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012347/doc4.xml","form_type":"4"}},{"id":379875,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-19T21:18:18.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":4666,"price":211.83,"value":988398.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $211.83 (range $211.25 to $212.24)."}],"balance_after":38433,"source":{"system":"sec-edgar","filing":"0001209191-21-012347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012347/doc4.xml","form_type":"4"}},{"id":379874,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-19T21:18:18.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1007,"price":210.08,"value":211550.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $210.08 (range $209.60 to $210.54)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":43099,"source":{"system":"sec-edgar","filing":"0001209191-21-012347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012347/doc4.xml","form_type":"4"}},{"id":379873,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-19T21:18:18.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":6240,"price":211.75,"value":1321320.0,"ownership":{"direct":true},"balance_after":44106,"source":{"system":"sec-edgar","filing":"0001209191-21-012347","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121012347/doc4.xml","form_type":"4"}},{"id":380323,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-16T21:15:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":200,"price":211.97,"value":42394.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $211.97 (range $211.97 to $211.98)."}],"balance_after":50346,"source":{"system":"sec-edgar","filing":"0001209191-21-010703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010703/doc4.xml","form_type":"4"}},{"id":380322,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-16T21:15:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":300,"price":211.21,"value":63363.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $211.21 (range $210.97 to $211.33)."}],"balance_after":50546,"source":{"system":"sec-edgar","filing":"0001209191-21-010703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010703/doc4.xml","form_type":"4"}},{"id":380321,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-16T21:15:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":3818,"price":210.43,"value":803421.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $210.43 (range $209.95 to $210.94)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":50846,"source":{"system":"sec-edgar","filing":"0001209191-21-010703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010703/doc4.xml","form_type":"4"}},{"id":380488,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-12T21:12:12.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":2563,"price":214.16,"value":548892.08,"ownership":{"direct":true},"balance_after":54664,"source":{"system":"sec-edgar","filing":"0001209191-21-010112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010112/doc4.xml","form_type":"4"}},{"id":380666,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-10T00:44:26.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":1930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":1930},"source":{"system":"sec-edgar","filing":"0001209191-21-009033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121009033/doc4.xml","form_type":"4"}},{"id":380665,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-10T00:44:26.000Z","date":"2021-02-05","kind":"sale","acquired":false,"shares":1930,"price":215,"value":414950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":57227,"source":{"system":"sec-edgar","filing":"0001209191-21-009033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121009033/doc4.xml","form_type":"4"}},{"id":380664,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-10T00:44:26.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":1930,"price":86.52,"value":166983.6,"ownership":{"direct":true},"balance_after":59157,"source":{"system":"sec-edgar","filing":"0001209191-21-009033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121009033/doc4.xml","form_type":"4"}},{"id":380796,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to buy)","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Fully vested."}],"balance_after":1930,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":380795,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":100,"price":218.2,"value":21820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":57227,"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":380794,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":100,"price":217,"value":21700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":57327,"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":380793,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":200,"price":215.52,"value":43104.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $215.52 (range $215.47 to $215.58)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":57427,"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":380792,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":400,"price":86.52,"value":34608.0,"ownership":{"direct":true},"balance_after":57627,"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":380791,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":11627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/17/2022."}],"balance_after":57227,"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":380790,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":10324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest in installments beginning on 02/10/2021."}],"balance_after":45600,"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":380789,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2021-02-05T21:52:16.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":8438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2018 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/03/2021 and the shares will vest on 02/17/2021."}],"balance_after":35276,"source":{"system":"sec-edgar","filing":"0001209191-21-008132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008132/doc4.xml","form_type":"4"}},{"id":383795,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-18T21:12:26.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":25,"price":224.34,"value":5608.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $224.34 (range $224.02 to $224.92)."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-059059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120059059/doc4.xml","form_type":"4"}},{"id":383794,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-18T21:12:26.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":40,"price":223.67,"value":8946.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $223.67 (range $223.01 to $224.00)."}],"balance_after":26863,"source":{"system":"sec-edgar","filing":"0001209191-20-059059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120059059/doc4.xml","form_type":"4"}},{"id":383793,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-18T21:12:26.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":26,"price":222.52,"value":5785.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $222.52 (range $221.98 to $222.97)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":26903,"source":{"system":"sec-edgar","filing":"0001209191-20-059059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120059059/doc4.xml","form_type":"4"}},{"id":384247,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T21:09:44.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":2330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in 16 quarterly installments from 02/03/2017."}],"balance_after":2330,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":2330},"source":{"system":"sec-edgar","filing":"0001209191-20-057275","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057275/doc4.xml","form_type":"4"}},{"id":384246,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-06T21:09:44.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":200,"price":221.25,"value":44250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $221.25 (range $221.09 to $221.42)."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-057275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057275/doc4.xml","form_type":"4"}},{"id":384245,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-06T21:09:44.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":300,"price":220.1,"value":66030.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $220.10 (range $219.78 to $220.56)."}],"balance_after":27038,"source":{"system":"sec-edgar","filing":"0001209191-20-057275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057275/doc4.xml","form_type":"4"}},{"id":384244,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-06T21:09:44.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":600,"price":218.63,"value":131178.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $218.63 (range $218.08 to $218.95)."}],"balance_after":27338,"source":{"system":"sec-edgar","filing":"0001209191-20-057275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057275/doc4.xml","form_type":"4"}},{"id":384243,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-06T21:09:44.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":600,"price":217.2,"value":130320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $217.20 (range $216.83 to $217.65)."}],"balance_after":27938,"source":{"system":"sec-edgar","filing":"0001209191-20-057275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057275/doc4.xml","form_type":"4"}},{"id":384242,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-06T21:09:44.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":630,"price":215.16,"value":135550.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $215.16 (range $215.00 to $215.67)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":28538,"source":{"system":"sec-edgar","filing":"0001209191-20-057275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057275/doc4.xml","form_type":"4"}},{"id":384241,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-11-06T21:09:44.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":2330,"price":86.52,"value":201591.6,"ownership":{"direct":true},"balance_after":29168,"source":{"system":"sec-edgar","filing":"0001209191-20-057275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120057275/doc4.xml","form_type":"4"}},{"id":387448,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-10T20:22:26.000Z","date":"2020-08-06","kind":"exercise","acquired":false,"shares":1223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in 16 quarterly installments from 02/06/2018."}],"balance_after":7338,"derivative":{"exercise_price":155.57,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":1223},"source":{"system":"sec-edgar","filing":"0001209191-20-045939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045939/doc4.xml","form_type":"4"}},{"id":387447,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-10T20:22:26.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":311,"price":272.53,"value":84756.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $272.53 (range $272.16 to $272.86)."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-045939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045939/doc4.xml","form_type":"4"}},{"id":387446,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-10T20:22:26.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":422,"price":271.45,"value":114551.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $270.13 (range $269.73 to $270.59)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $271.45 (range $270.94 to $271.88)."}],"balance_after":27149,"source":{"system":"sec-edgar","filing":"0001209191-20-045939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045939/doc4.xml","form_type":"4"}},{"id":387445,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-10T20:22:26.000Z","date":"2020-08-06","kind":"sale","acquired":false,"shares":490,"price":270.13,"value":132363.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $270.13 (range $269.73 to $270.59)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":27571,"source":{"system":"sec-edgar","filing":"0001209191-20-045939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045939/doc4.xml","form_type":"4"}},{"id":387444,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-10T20:22:26.000Z","date":"2020-08-06","kind":"exercise","acquired":true,"shares":1223,"price":155.57,"value":190262.11,"ownership":{"direct":true},"balance_after":28061,"source":{"system":"sec-edgar","filing":"0001209191-20-045939","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045939/doc4.xml","form_type":"4"}},{"id":387555,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:20:47.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":2330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in 16 quarterly installments from 02/03/2017."}],"balance_after":4660,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":2330},"source":{"system":"sec-edgar","filing":"0001209191-20-045101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045101/doc4.xml","form_type":"4"}},{"id":387554,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-05T20:20:47.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":730,"price":279.41,"value":203969.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $279.41 (range $279.03 to $279.70)."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-045101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045101/doc4.xml","form_type":"4"}},{"id":387553,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-05T20:20:47.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":1100,"price":278.13,"value":305943.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $278.13 (range $277.73 to $278.58)."}],"balance_after":27568,"source":{"system":"sec-edgar","filing":"0001209191-20-045101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045101/doc4.xml","form_type":"4"}},{"id":387552,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-05T20:20:47.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":500,"price":276.98,"value":138490.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $276.98 (range $276.60 to $277.39)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":28668,"source":{"system":"sec-edgar","filing":"0001209191-20-045101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045101/doc4.xml","form_type":"4"}},{"id":387551,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-08-05T20:20:47.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":2330,"price":86.52,"value":201591.6,"ownership":{"direct":true},"balance_after":29168,"source":{"system":"sec-edgar","filing":"0001209191-20-045101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120045101/doc4.xml","form_type":"4"}},{"id":388294,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"exercise","acquired":false,"shares":2125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":90.29,"expiration_date":"2026-07-11","underlying":"Common Stock","underlying_shares":2125},"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388293,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":100,"price":296.48,"value":29648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388292,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":300,"price":295.38,"value":88614.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $295.38 (range $295.16 to $295.70)."}],"balance_after":26938,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388291,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":800,"price":294.57,"value":235656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $294.57 (range $294.15 to $295.02)."}],"balance_after":27238,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388290,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":200,"price":292.76,"value":58552.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $292.76 (range $292.46 to $293.05)."}],"balance_after":28038,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388289,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":100,"price":290.65,"value":29065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":28238,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388288,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":200,"price":288.57,"value":57714.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $288.57 (range $288.14 to $288.99)."}],"balance_after":28338,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388287,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":100,"price":286.57,"value":28657.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":28538,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388286,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":225,"price":285.67,"value":64275.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $285.67 (range $285.57 to $285.77)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":28638,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388285,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":100,"price":284.28,"value":28428.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":28863,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":388284,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-07-15T20:41:33.000Z","date":"2020-07-13","kind":"exercise","acquired":true,"shares":2125,"price":90.29,"value":191866.25,"ownership":{"direct":true},"balance_after":28963,"source":{"system":"sec-edgar","filing":"0001209191-20-042488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120042488/doc4.xml","form_type":"4"}},{"id":390360,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":9,"price":288.23,"value":2594.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Open market sales reported on this line occurred at a weighted average price of $288.23 (range $287.96 to $288.47)."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390359,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":18,"price":287.5,"value":5175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Open market sales reported on this line occurred at a weighted average price of $287.50 (range $286.96 to $287.88)."}],"balance_after":26847,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390358,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":9,"price":286.27,"value":2576.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $286.27 (range $285.70 to $286.68)."}],"balance_after":26865,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390357,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":4,"price":285.19,"value":1140.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $285.19 (range $284.70 to $285.63)."}],"balance_after":26874,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390356,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":3,"price":284.03,"value":852.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $284.03 (range $283.56 to $284.37)."}],"balance_after":26878,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390355,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":4,"price":283.03,"value":1132.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $283.03 (range $282.45 to $283.31)."}],"balance_after":26881,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390354,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":4,"price":282.02,"value":1128.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $282.02 (range $281.42 to $282.38)."}],"balance_after":26885,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390353,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":11,"price":280.34,"value":3083.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $280.34 (range $279.74 to $280.73)."}],"balance_after":26889,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390352,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":1,"price":278.69,"value":278.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":26900,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390351,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":2,"price":276.46,"value":552.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $276.46 (range $276.44 to $276.49)."}],"balance_after":26901,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390350,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":2,"price":275.54,"value":551.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $275.54 (range $275.25 to $275.83)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":26903,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390349,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-19T20:28:23.000Z","date":"2020-05-15","kind":"sale","acquired":false,"shares":1,"price":273.91,"value":273.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":26905,"source":{"system":"sec-edgar","filing":"0001209191-20-030479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120030479/doc4.xml","form_type":"4"}},{"id":390714,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-13T20:18:55.000Z","date":"2020-05-11","kind":"exercise","acquired":false,"shares":1304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 02/06/2019."}],"balance_after":14338,"derivative":{"exercise_price":187.53,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":1304},"source":{"system":"sec-edgar","filing":"0001209191-20-028797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120028797/doc4.xml","form_type":"4"}},{"id":390713,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-13T20:18:55.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":1304,"price":286,"value":372944.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-028797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120028797/doc4.xml","form_type":"4"}},{"id":390712,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-13T20:18:55.000Z","date":"2020-05-11","kind":"exercise","acquired":true,"shares":1304,"price":187.53,"value":244539.12,"ownership":{"direct":true},"balance_after":28142,"source":{"system":"sec-edgar","filing":"0001209191-20-028797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120028797/doc4.xml","form_type":"4"}},{"id":390926,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-08T20:22:01.000Z","date":"2020-05-06","kind":"exercise","acquired":false,"shares":1222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in 16 quarterly installments from 02/06/2018."}],"balance_after":8561,"derivative":{"exercise_price":155.57,"expiration_date":"2028-02-05","underlying":"Common Stock","underlying_shares":1222},"source":{"system":"sec-edgar","filing":"0001209191-20-027894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027894/doc4.xml","form_type":"4"}},{"id":390925,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-08T20:22:01.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":70,"price":274.73,"value":19231.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-027894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027894/doc4.xml","form_type":"4"}},{"id":390924,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-08T20:22:01.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":420,"price":273.96,"value":115063.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $273.96 (range $273.68 to $274.31)."}],"balance_after":26908,"source":{"system":"sec-edgar","filing":"0001209191-20-027894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027894/doc4.xml","form_type":"4"}},{"id":390923,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-08T20:22:01.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":319,"price":273,"value":87087.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $273.00 (range $272.66 to $273.44)."}],"balance_after":27328,"source":{"system":"sec-edgar","filing":"0001209191-20-027894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027894/doc4.xml","form_type":"4"}},{"id":390922,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-08T20:22:01.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":140,"price":271.64,"value":38029.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $271.64 (range $271.55 to $271.73)."}],"balance_after":27647,"source":{"system":"sec-edgar","filing":"0001209191-20-027894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027894/doc4.xml","form_type":"4"}},{"id":390921,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-08T20:22:01.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":273,"price":270.16,"value":73753.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $270.16 (range $269.77 to $270.75)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":27787,"source":{"system":"sec-edgar","filing":"0001209191-20-027894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027894/doc4.xml","form_type":"4"}},{"id":390920,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-08T20:22:01.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":1222,"price":155.57,"value":190106.54,"ownership":{"direct":true},"balance_after":28060,"source":{"system":"sec-edgar","filing":"0001209191-20-027894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027894/doc4.xml","form_type":"4"}},{"id":391117,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T20:25:09.000Z","date":"2020-05-04","kind":"exercise","acquired":false,"shares":2330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in 16 quarterly installments from 02/03/2017."}],"balance_after":6990,"derivative":{"exercise_price":86.52,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":2330},"source":{"system":"sec-edgar","filing":"0001209191-20-027472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027472/doc4.xml","form_type":"4"}},{"id":391116,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-06T20:25:09.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":181,"price":264.82,"value":47932.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $264.82 (range $264.77 to $264.89)."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-027472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027472/doc4.xml","form_type":"4"}},{"id":391115,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-06T20:25:09.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":554,"price":262.48,"value":145413.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $262.48 (range $261.98 to $262.94)."}],"balance_after":27019,"source":{"system":"sec-edgar","filing":"0001209191-20-027472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027472/doc4.xml","form_type":"4"}},{"id":391114,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-06T20:25:09.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":195,"price":261.21,"value":50935.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $261.21 (range $260.88 to $261.56)."}],"balance_after":27573,"source":{"system":"sec-edgar","filing":"0001209191-20-027472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027472/doc4.xml","form_type":"4"}},{"id":391113,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-06T20:25:09.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":700,"price":260.16,"value":182112.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $260.16 (range $259.74 to $260.64)."}],"balance_after":27768,"source":{"system":"sec-edgar","filing":"0001209191-20-027472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027472/doc4.xml","form_type":"4"}},{"id":391112,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-06T20:25:09.000Z","date":"2020-05-04","kind":"sale","acquired":false,"shares":700,"price":259.19,"value":181433.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $259.19 (range $258.74 to $259.63)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":28468,"source":{"system":"sec-edgar","filing":"0001209191-20-027472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027472/doc4.xml","form_type":"4"}},{"id":391111,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-06T20:25:09.000Z","date":"2020-05-04","kind":"exercise","acquired":true,"shares":2330,"price":86.52,"value":201591.6,"ownership":{"direct":true},"balance_after":29168,"source":{"system":"sec-edgar","filing":"0001209191-20-027472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120027472/doc4.xml","form_type":"4"}},{"id":391342,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"exercise","acquired":false,"shares":2125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in 16 quarterly installments from 07/12/2016."}],"balance_after":2125,"derivative":{"exercise_price":90.29,"expiration_date":"2026-07-11","underlying":"Common Stock","underlying_shares":2125},"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":391341,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":100,"price":258.15,"value":25815.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":391340,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":500,"price":256.63,"value":128315.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $256.63 (range $256.35 to $256.96)."}],"balance_after":26938,"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":391339,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":680,"price":255.44,"value":173699.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $255.44 (range $255.03 to $255.97)."}],"balance_after":27438,"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":391338,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":400,"price":254.2,"value":101680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $254.20 (range $253.60 to $254.55)."}],"balance_after":28118,"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":391337,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":300,"price":252.7,"value":75810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $252.70 (range $252.48 to $252.96)."}],"balance_after":28518,"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":391336,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":145,"price":251.38,"value":36450.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $251.38 (range $251.37 to $251.38)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":28818,"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":391335,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Adm, Leg & BD Off"}}],"security":"Common Stock","published_at":"2020-05-01T20:22:57.000Z","date":"2020-04-29","kind":"exercise","acquired":true,"shares":2125,"price":90.29,"value":191866.25,"ownership":{"direct":true},"balance_after":28963,"source":{"system":"sec-edgar","filing":"0001209191-20-026529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120026529/doc4.xml","form_type":"4"}},{"id":394359,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CL&AO"}}],"security":"Common Stock","published_at":"2020-02-26T21:35:25.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":480,"price":238.3,"value":114384.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $238.30 (range $238.16 to $238.54)."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001209191-20-013032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013032/doc4.xml","form_type":"4"}},{"id":394358,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CL&AO"}}],"security":"Common Stock","published_at":"2020-02-26T21:35:25.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":320,"price":236.26,"value":75603.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $236.26 (range $235.72 to $236.80)."}],"balance_after":27318,"source":{"system":"sec-edgar","filing":"0001209191-20-013032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013032/doc4.xml","form_type":"4"}},{"id":394357,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CL&AO"}}],"security":"Common Stock","published_at":"2020-02-26T21:35:25.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":640,"price":234.77,"value":150252.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $234.77 (range $234.51 to $235.46)."}],"balance_after":27638,"source":{"system":"sec-edgar","filing":"0001209191-20-013032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013032/doc4.xml","form_type":"4"}},{"id":394356,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CL&AO"}}],"security":"Common Stock","published_at":"2020-02-26T21:35:25.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":320,"price":232.89,"value":74524.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $232.89 (range $232.73 to $233.05)."}],"balance_after":28278,"source":{"system":"sec-edgar","filing":"0001209191-20-013032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013032/doc4.xml","form_type":"4"}},{"id":394355,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CL&AO"}}],"security":"Common Stock","published_at":"2020-02-26T21:35:25.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":330,"price":231.62,"value":76434.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $231.62 (range $231.12 to $232.06)."}],"balance_after":28598,"source":{"system":"sec-edgar","filing":"0001209191-20-013032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013032/doc4.xml","form_type":"4"}},{"id":394354,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":1676,"kind":"person","name":"Parini Michael","position":1,"cik":"0001661567","reported_name":"Parini Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CL&AO"}}],"security":"Common Stock","published_at":"2020-02-26T21:35:25.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":938,"price":230.07,"value":215805.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $230.07 (range $229.75 to $230.57)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":28928,"source":{"system":"sec-edgar","filing":"0001209191-20-013032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919120013032/doc4.xml","form_type":"4"}}],"next_cursor":"2020-02-26T21:35:25.000000Z,394354"}